Lawrie William Powell

Q: What Schools Are Affiliated With Lawrie William Powell

Lawrie William Powell is affiliated with the following schools: University of Queensland

Lawrie William Powell's AcademicInfluence.com Rankings

Philosophy

#5806

World Rank

#8709

Historical Rank

Logic

#3021

World Rank

#4113

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Lawrie William Powell's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Lawrie William Powell Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Lawrie William Powell's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases (2011) (700)
A population-based study of the clinical expression of the hemochromatosis gene. (1999) (669)
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. (1998) (651)
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis (2003) (616)
Iron-overload-related disease in HFE hereditary hemochromatosis. (2008) (519)
Iron Metabolism in Health and Disease (1994) (363)
Haemochromatosis and HLA–H (1996) (333)
Hereditary hemochromatosis: gene discovery and its implications for population-based screening. (1998) (290)
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation (2014) (278)
EASL International Consensus Conference on Haemochromatosis. (2000) (277)
Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. (2002) (254)
A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. (2002) (243)
Factors affecting the concentrations of ferritin in serum in a healthy Australian population. (1990) (219)
Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. (1985) (213)
Management of Hemochromatosis (1998) (190)
Screening for hemochromatosis in asymptomatic subjects with or without a family history. (2006) (188)
Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. (2002) (175)
Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. (1998) (166)
Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. (2000) (164)
Preneoplastic significance of hepatic iron–free foci in genetic hemochromatosis: A study of 185 patients (1993) (159)
Steatosis is a cofactor in liver injury in hemochromatosis. (2005) (158)
Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. (2001) (155)
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. (1967) (146)
Enhanced drug metabolism in cigarette smokers. (1976) (142)
Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index (1990) (140)
Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. (1998) (139)
Differentiation Between Heterozygotes and Homozygotes in Genetic Hemochromatosis by Means of a Histological Hepatic Iron Index: A Study of 192 Cases (1993) (139)
Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3 (2001) (136)
Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes (1979) (133)
Haemochromatosis in the new millennium. (2000) (127)
Diagnosis of hemochromatosis in young subjects: Predictive accuracy of biochemical screening tests (1984) (125)
Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding (1972) (125)
Management of hemochromatosis. Hemochromatosis Management Working Group. (1998) (119)
The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. (1998) (117)
THE NATURE OF PIECEMEAL NECROSIS IN CHRONIC ACTIVE HEPATITIS (1979) (116)
Hemochromatosis: 1980 update (1980) (112)
Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis (1997) (111)
Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. (1997) (107)
The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis (1986) (107)
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis (2010) (103)
Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. (1990) (101)
Solid phase radioimmunoassay for serum ferritin (1975) (100)
Localization of the hemochromatosis gene close to D6S105. (1993) (99)
Normal serum ferritin concentrations in precirrhotic hemochromatosis. (1976) (99)
Detection and isolation of a hepatic membrane receptor for ferritin. (1983) (98)
Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. (2001) (97)
Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments. (1994) (96)
Human Isoferritins: Organ Specific Iron and Apoferritin Distribution (1975) (96)
Dose‐dependent pharmacokinetics of caffeine in humans: Relevance as a test of quantitative liver function (1990) (94)
Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality (1970) (94)
The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. (2006) (93)
Association between alcoholism and increased hepatic iron stores. (1988) (90)
Reversal of "cirrhosis" in idiopathic haemochromatosis following long-term intensive venesection therapy. (1970) (90)
Detection of male DNA in the liver of female patients with primary biliary cirrhosis. (2000) (87)
Hemochromatosis and alcoholic liver disease. (2003) (85)
Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. (2008) (84)
Smoking, obesity, and hypertension alter the dose-response curve and test sensitivity of carbohydrate-deficient transferrin as a marker of alcohol intake. (1998) (84)
Iron storage disorders of the liver. (1974) (83)
Clinical aspects of hemochromatosis. (2005) (81)
A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient (2003) (80)
Improvement in chronic hepatocerebral degeneration following liver transplantation. (1990) (78)
Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. (1995) (73)
Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. (1995) (73)
Universal occurrence of glomerular abnormalities in patients receiving liver transplants. (1992) (72)
Treatment of non‐resectable hepatocellular carcinoma with autologous tumor‐pulsed dendritic cells (2002) (70)
Desialylated transferrin and mitochondrial aspartate aminotransferase compared as laboratory markers of excessive alcohol consumption. (1990) (70)
Haemochromatosis (2016) (69)
Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. (1978) (68)
Use of chromatofocusing to detect a transferrin variant in serum of alcoholic subjects. (1985) (67)
SERUM-FERRITIN IN DIAGNOSIS OF HÆMOCHROMATOSIS A Study of 43 Families (1977) (64)
Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. (1992) (63)
Relative importance of female‐specific and non‐female‐specific effects on variation in iron stores between women (2003) (63)
Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. (1997) (62)
Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. (1999) (61)
The Kinetics of Serum and Tissue Ferritins: Relation to Carbohydrate Content (1979) (60)
Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women. (2000) (60)
Duodenal expression of iron transport molecules in untreated haemochromatosis subjects (2003) (60)
Ultrastructural sequences during liver iron overload in genetic hemochromatosis. (1997) (57)
Changing concepts in haemochromatosis. (1970) (54)
Apoptosis as the mode of cell death in antibody-dependent lymphocytotoxicity. (1985) (54)
Transferrin receptor distribution and regulation in the rat small intestine: Effect of iron stores and erythropoiesis (1990) (52)
Abnormality in tissue isoferritin distribution in idiopathic haemochromatosis (1974) (52)
Abnormal liver function in chronic hypervitaminosis A (1977) (52)
Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. (1984) (51)
Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. (2002) (50)
Diagnosis of hemochromatosis. (2002) (48)
Effects of iron loading on free radical scavenging enzymes and lipid peroxidation in rat liver. (1989) (48)
INFLUENCE OF ALCOHOL AND CAFFEINE CONSUMPTION ON CAFFEINE ELIMINATION (1986) (47)
Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression. (1999) (47)
Iron status and cellular immune competence. (1988) (47)
The measurement of sulphated and non-sulphated bile acids in serum using gas-liquid chromatography. (1975) (46)
Primary intrahepatic obliterating cholangitis: a possible variant of `sclerosing cholangitis' (1969) (45)
Pituitary function in idiopathic haemochromatosis and cirrhosis of the liver. (1972) (45)
Alterations in the liver with ageing. (1985) (45)
Iron storage in relatives of patients with haemochromatosis and in relatives of patients with alcoholic cirrhosis and haemosederosis (1965) (44)
The global burden of iron overload (2009) (43)
The endocytosis of transferrin by rat intestinal epithelial cells. (1994) (42)
Effect of initial treatment of chronic inflammatory periodontal disease on the frequency of peripheral blood T-lymphocytes specific to periodontopathic bacteria. (1991) (41)
Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea. (2018) (41)
EARLY DETECTION OF IDIOPATHIC HÆMOCHROMATOSIS: RELATIVE VALUE OF SERUM-FERRITIN AND HLA TYPING (1979) (41)
The pathology of the liver in hemochromatosis. (1975) (41)
Relationship between serum ferritin and total body iron stores in idiopathic haemochromatosis. (1978) (40)
Differential regulation of ferritin H and L subunit mRNA during inflammation and long‐term iron overload (1993) (40)
DEMONSTRATION OF PREVIOUSLY UNDETECTED HEPATITIS B VIRAL DETERMINANTS IN AN AUSTRALIAN ABORIGINAL POPULATION BY MONOCLONAL ANTI-HBs ANTIBODY RADIOIMMUNOASSAYS (1982) (40)
Hemochromatosis and Other Iron Storage Disorders (1984) (39)
Neonatal screening for the hemochromatosis defect. (1997) (39)
Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease. (2018) (38)
Non-alcoholic fatty liver disease: is iron relevant? (2011) (38)
Characterization of the binding of ferritin to the rat liver ferritin receptor. (1985) (38)
Transferrin receptor distribution and regulation in the rat small intestine. Effect of iron stores and erythropoiesis. (1990) (38)
Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic? (1995) (37)
Does transplantation of the liver cure genetic hemochromatosis? (1992) (36)
Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation. (1998) (36)
Natural history and management of HFE-hemochromatosis. (2011) (36)
Immunological detection of isoferritins in normal human serum and tissue. (1976) (35)
Iron and coronary heart disease. (1993) (34)
Liver disease associated with chronic arsenic ingestion. (1979) (34)
Ferritin synthesis in peripheral blood monocytes in idiopathic hemochromatosis. (1982) (34)
Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. (2003) (33)
An assessment of red cell survival in idiopathic unconjugated hyperbilirubinaemia (Gilbert's syndrome) by the use of radioactive diisopropylfluorophosphate and chromium. (1967) (33)
Effects of Body Iron Stores and Haemochromatosis Genotypes on Coronary Heart Disease Outcomes in the Busselton Health Study (2002) (33)
Carbohydrate intolerance in idiopathic haemochromatosis and cirrhosis of the liver. (1973) (32)
Acute meprobamate poisoning. (1958) (32)
Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis (2000) (32)
Limit dilution analysis of peripheral blood T lymphocytes specific to periodontopathic bacteria. (1989) (31)
A 4.5-megabase YAC contig and physical map over the hemochromatosis gene region. (1996) (31)
Hemochromatosis: 1980 update. (1980) (31)
Characterization of the ferritin receptors of human T lymphoid (MOLT-4) cells. (1992) (31)
Specific Immunodiagnosis of Hepatocellular Carcinoma by Leucocyte Adherence Inhibition (1974) (30)
Sarcoidosis of skeletal muscle; report of 6 cases and review of the literature. (1953) (30)
Isolation of CA dinucleotide repeats close to D6S105; linkage disequilibrium with haemochromatosis. (1994) (29)
Hemochromatosis: the impact of early diagnosis and therapy. (1996) (29)
Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial. (2017) (29)
The haemochromatosis gene: A co‐factor for chronic liver diseases? (1999) (29)
Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis. (2005) (29)
Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone. (1979) (28)
Idiopathic haemochromatosis in the Australian population: HLA linkage and recessivity. (1981) (28)
Recent advances in hemochromatosis: a 2015 update (2015) (28)
Recurrent hepatitis in patients receiving multiple halothane anesthetics for radium treatment of carcinoma of the cervix uteri. (1970) (28)
A novel mutation in ferroportin implicated in iron overload. (2007) (27)
Sulindac hepatotoxicity: effects of acute and chronic exposure. (1985) (27)
Regulation of Plasma Ferritin by the Isolated Perfused Rat Liver (1981) (27)
Hemojuvelin (HJV)-associated hemochromatosis: analysis of HJV and HFE mutations and iron overload in three families. (2005) (26)
Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration. (1981) (26)
The effect of experimental iron-overload on splenic T cell function: analysis using cloning techniques. (1987) (26)
Isoferritin composition of tissues and serum in human cancers. (1976) (26)
Genetics of hemochromatosis. (1999) (25)
Hereditary hemochromatosis genetic testing of at-risk children: what is the appropriate age? (2004) (25)
Hemochromatosis in heterozygotes. (1996) (24)
Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis. (2001) (24)
Physical and genetic mapping of the telomeric major histocompatibility complex region in man and relevance to the primary hemochromatosis gene (HFE). (1992) (24)
Haemosiderosis associated with xanthine oxidase inhibition. (1966) (24)
What’s new in hemochromatosis (2001) (24)
Porphyria cutanea tarda and HLA-linked hemochromatosis--all in the family? (1987) (24)
HLA determinants in an Australian population of hemochromatosis patients and their families. (1989) (24)
Normal human iron storage and its relation to ethanol consumption. (1966) (23)
Haemochromatosis: a clinical update for the practising physician (2018) (23)
Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use. (1979) (23)
Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: implications for family screening. (2002) (23)
Australia antigen in active chronic hepatitis in Australia: results in 130 patients from three centres. (1972) (22)
Hemochromatosis: genetics and pathogenesis. (1996) (22)
Flucloxacillin associated cholestatic hepatitis (1995) (21)
Alterations in tissue ferritins in iron storage disorders. (1975) (21)
3-Methylcholanthrene inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes depends upon the extent of blast transformation. (1977) (21)
Duodenal ferritin content and structure: relationship with body iron stores in man. (1978) (21)
Psychological Adjustment and Knowledge About Hereditary Hemochromatosis in a Clinic-Based Sample: A Prospective Study (2005) (20)
The Queensland Liver Transplant Programme: the first two years. (1987) (20)
Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE. (2020) (19)
Early diagnosis and treatment of hemochromatosis. (1989) (19)
Isolation of a porcine hepatic ferritin receptor. (1988) (19)
HFE and Non-HFE Hemochromatosis (2002) (19)
The use of suspensions of isolated rat mucosal cells to study mechanisms of iron absorption. (1973) (19)
Failure of a Pure Progestogen Contraceptive to Affect Serum Levels of Iron, Transferrin, Protein-bound Iodine, and Transaminase (1970) (18)
Simple radioimmunoassay for transferrin using insolubilized antitransferrin antibodies: its application to cultured cells. (1986) (18)
Postprandial changes in serum concentrations of individual bile salts in normal subjects and patients with acute viral hepatitis (1978) (18)
HFE-associated hereditary hemochromatosis. (2000) (18)
Improved purification of the human placental transferrin receptor and a novel immunoradiometric assay for receptor protein. (1986) (18)
IDIOPATHIC HAEMOCHROMATOSIS IN MENSTRUATING WOMEN. A FAMILY STUDY, INCLUDING THE USE OF DIETHYLENE TRIAMINE PENTA-ACETIC ACID. (1964) (17)
More clues to the relationship between hepatic iron and steatosis: An association with insulin resistance? (1999) (17)
Ferritin metabolism and the liver. (1984) (17)
Increased duodenal expression of divalent metal transporter 1 and iron‐regulated gene 1 in cirrhosis (2004) (16)
Hemolysis after heterograft and prosthetic valve replacement. (1970) (16)
Guillain Barré syndrome during the pre-icteric phase of acute type B viral hepatitis. (1975) (16)
Idiopathic Haemochromatosis (1967) (15)
HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype‐stratified cohort study of hemochromatosis in Australian women (2017) (15)
Mononuclear Cell Factors that Inhibit Fibroblast Collagen Synthesis (1983) (15)
Of metals, mice, and men: what animal models can teach us about body iron loading. (2000) (15)
Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores (1967) (15)
Iron overload complicating sideroblastic anemia--is the gene for hemochromatosis responsible? (1989) (15)
The diagnosis and management of hereditary haemochromatosis. (2010) (14)
Rapid, sensitive method for the separation of free cholesterol from ester cholesterol. (1973) (14)
The effect of iron (Fe3+) on the cloning efficiency of human memory T4+ lymphocytes. (1986) (14)
Primary sarcoma of the liver. Report of a case with excellent response to hepatic artery ligation and infusion chemotherapy. (1978) (14)
Red Cell Survival after Heterograft Valve Surgery (1968) (14)
Cell-mediated immunity to liver antigen in toxic liver injury. II. Role in pathogenesis of liver damage. (1980) (14)
The effect of non-transferrin-bound iron on murine T lymphocyte subsets: analysis by clonal techniques. (1987) (13)
HFE C 282 Y Homozygotes Are at Increased Risk of Breast and Colorectal Cancer (2010) (13)
Clinical expression of the hemochromatosis gene in a stable non-blood bank population: A longitudinal study of the Busselton population (1999) (13)
Sensitive and rapid colorimetric immunoenzymometric assay of ferritin in biological samples. (1990) (13)
The incidence of oxyphenisatin ingestion in active chronic hepatitis: a prospective controlled study of 29 patients. (1973) (13)
Iron storage in relatives of patients with haemochromatosis and in relatives of patients with alcoholic cirrhosis and haemosiderosis. A comparative study of 27 families. (1965) (13)
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron) (2015) (13)
Cell-mediated immunity to liver antigen in toxic liver injury. I. Occurrence and specificity. (1980) (13)
Urinary iron excretion in valvular heart disease and after heart valve replacement. (1970) (12)
In-vivo intestinal mucosal uptake of iron, body iron absorption and gastric juice iron-binding in idiopathic haemochromatosis. (1970) (12)
Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE. (2020) (12)
Haemochromatosis: diagnosis and management after the cloning of the HFE gene. (1998) (12)
Effect of cell proliferation on H-ferritin receptor expression in human T lymphoid (MOLT-4) cells. (1992) (12)
GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes. (2016) (12)
Evidence for altered hepatic matrix degradation in genetic haemochromatosis (1998) (12)
Are the causes and presentation of chronic hepatitis changing? An analysis of 104 cases over 15 years. (1984) (11)
Red Cell Survival in Experimental Cholestatic Jaundice (1968) (11)
Distribution of body water in patients with cirrhosis: The effect of liver transplantation (1993) (11)
Population screening for HFE‐associated haemochromatosis: should we have to pay for our genes? (2001) (11)
Identification of a novel Krueppel-related zinc finger gene (ZNF184) mapping to 6p21.3. (1997) (10)
Ferritin and Cellular Iron Metabolism a (1988) (10)
The effect of iron and ethanol on rat hepatocyte collagen synthesis. (1991) (10)
Factors influencing disease expression in hemochromatosis. (1996) (10)
Genetic hemochromatosis. (1984) (10)
Alcohol and the liver. (1979) (9)
The relationship of red cell membrane lipid content to red cell morphology and survival in patients with liver disease. (1975) (9)
Transient intravascular haemolysis associated with alcoholic liver disease and hyperlipidaemia. (1972) (9)
BROADSHEET NUMBER 54: HEREDITARY HEMOCHROMATOSIS (2000) (9)
Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism. (1977) (9)
Idiopathic hemochromatosis: demonstration of homozygous-heterozygous mating by HLA typing of families (2004) (9)
Evidence for altered hepatic matrix degradation in genetic haemochromatosis. (1998) (9)
Erythromycin jaundice: diagnosis by an in vitro challenge test. (1977) (9)
Haemolysis in experimental cholestasis: Possible role of erythrocyte sialic acid (1974) (9)
A new look at ferritin metabolism. (1994) (9)
Effect of colchicine on the clearance of ferritin in vivo. (1990) (8)
Hemochromatosis--newer concepts: diagnosis and management. (1980) (8)
Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes. (2018) (8)
Serum ferritin and isoferritins in clinical medicine. (1979) (8)
Mononuclear Cell Factors that Inhibit Fibroblast Collagen Synthesis (1983) (8)
Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes. (2018) (8)
Haemochromatosis after the discovery of HFE (“HLA-H”) (1997) (8)
The Australian Tobacco Research Foundation (1988) (8)
187 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS: FINAL RESULTS (2009) (8)
How much iron is too much? (2008) (7)
A Phase I/II, Open-Label, Dose-Escalation Trial of Once-Daily Oral Chelator Deferasirox to Treat Iron Overload in HFE-Related Hereditary Hemochromatosis: Final Results of the Core Study. (2009) (7)
Haemochromatosis and control of intestinal iron absor ption (1999) (7)
8 The clinical manifestations of chronic iron overload (1989) (7)
Effect of Long‐term Corticosteroid Therapy on Monocyte Chemotaxis in Man (1980) (7)
Autoimmune Chronic Active Hepatitis Evolving to Primary Sclerosing Cholangitis - Evidence for a Common Pathogenesis (1992) (7)
Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials. (2015) (7)
Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis (2019) (7)
Cystic fibrosis of the pancreas complicated by myocardial fibrosis. (1957) (7)
Recent advances in iron metabolism. (1979) (7)
IDENTIFICATION OF HOMOZYGOTES FOR HEMOCHROMATOSIS BY MEASUREMENT OF THE HEPATIC IRON INDEX (1989) (7)
Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation (1999) (6)
Laboratory markers of alcoholism. (1989) (6)
Liver transplantation: an update for physicians. (1989) (6)
Detection of HFE Haemochromatosis in the clinic and community using standard erythrocyte tests. (2019) (6)
Cah or Sle? (1986) (6)
Iron overload. (1982) (6)
Effects of allopurinol on iron storage in the rat. (1966) (6)
Specific assays for prednisolone and prednisone in serum: Lipidex chromatography followed by radioimmunoassay (1978) (6)
Chronic granulomatous hepatitis. (1976) (5)
Management of human factors engineering-associated hemochromatosis: A 2015 update. (2016) (5)
Metabolic disorders of the liver (1996) (5)
A method for analysing the clonal precursors of concanavalin A-induced suppressor cells. (1985) (5)
The clinical manifestations of chronic iron overload. (1989) (5)
The interaction of cigarette smoking and chronic drug ingestion on human drug metabolism (1979) (5)
Use of Triton X-100 scintillant in a simple method for the simultaneous assay of 55Fe and 59Fe by liquid scintillation counting (1970) (5)
Carcinoma of the prostate with metastases to the testis. (1957) (5)
Expression of HLA-linked haemochromatosis in homozygous and heterozygous subjects diagnosed according to the C282Y mutation evaluation of previous diagnostic criteria (1997) (5)
Is hepatic iron the cause of raised serum transaminases in haemochromatosis (1998) (5)
Hepatocellular Carcinoma in Hemochromatosis (1987) (5)
The effect of iron, iron‐binding proteins and iron‐overload on human natural killer cell activity (1988) (5)
Clinical aspects of unconjugated hyperbilirubinemia. (1972) (4)
Sarcoidosis of the myocardium. (1954) (4)
Bridging the gap between basic science and clinical medicine: mentors and memories (2002) (4)
Reply: To PMID 25605615. (2015) (4)
Hemochromatosis: Ferritin metabolism in hemochromatosis (2000) (4)
Solid phase radioimmunossay for serum ferritin. (1975) (4)
EASL International Consensus Conference on Haemochromatosis Co-sponsored by the World Health Organization * (4)
Chromatographic detergent exchange in the preparation of membrane receptor protein. (1988) (4)
Solid phase immunoradiometric assay for porcine serum ferritin. (1988) (4)
ACUTE RENAL FAILURE COMPLICATING INTRAVENOUS CHOLANGIOGRAPHY IN A PATIENT WITH DUBIN‐JOHNSON SYNDROME (1969) (4)
Vitamin E deficiency in human liver disease and its relation to haemolysis. (1973) (4)
Automated measurement of unsaturated iron binding capacity allows a cost effective, ongoing strategy for screening for haemochromatosis (1998) (4)
Neomycin nephropathy. (1956) (4)
Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
Hepatitis B-antigen subtypes in Australia as detected by radioimmunoassay. (1976) (4)
Pyogenic liver abscess--a neglected diagnosis. (1984) (3)
Hepatology: A Textbook of Liver Disease, 2nd Edn., Zakim D., Boyer T.D. (Eds.). W.B. Saunders, Paris (1990) (1993) (3)
Steatohepatitis: comparison of alcoholic and non-alcoholic subjects with particular reference to portal hypertension and hepatic complications. (1989) (3)
Homozygosity for the C282Y mutation in the HFE gene is associated with increased risk of colorectailand breast cancer in Australian population (2007) (3)
Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening. (2002) (3)
IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes. (1989) (3)
Hemochromatosis: Management of hemochromatosis (2000) (3)
HFE genotype in patients with hemochromatosis and other liver diseases. (2000) (3)
The C282Y mutation in HFE is common in Australian patients and can act independently of HCV to precipitate porphyria cutanea tarda (1997) (3)
Is determination of the hepatic iron index of diagnostic value in patients with thalassemia minor and chronic alcoholic liver disease? (1991) (3)
The detection of IgG anti-hepatocyte antibodies by ELISA in sera of patients with chronic active hepatitis: correlation with disease activity. (1985) (2)
Elevated serum type IV collagen: a sensitive marker of severe fibrosis / cirrhosis in haemochromatosis (1998) (2)
Metals and the liver. (1978) (2)
The effect of acute liver damage on circulating ferritin levels in vivo and in the isolated perfused rat liver. (1985) (2)
Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels. (2019) (2)
Hemochromatosis and Vitamin C (1999) (2)
Primary intrahepatic obliterating cholangitis: a possible variant of 'sclerosing cholangitis'. (1969) (2)
Healthiron: a longitudinal population study defining the burden of disease in HFE-associated hereditary hemochromatosis (2007) (2)
Genetic and environmental factors influencing drug metabolism (1977) (2)
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis (2021) (2)
1059 The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D) (2003) (2)
Fine mapping of a human chromosome 6 ferritin heavy chain pseudogene: relevance to haemochromatosis (1991) (2)
Polymorphism in a ferritin H gene from chromosome 6p (1991) (2)
Drug Metabolism and Interaction with Particular Reference to the Liver (2012) (2)
Treatment of inflammatory and metal storage diseases of the liver. (1979) (2)
Iron, ferritin, and the liver. (1982) (2)
Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy. (2005) (2)
Overview: Liver disease and transplantation (2009) (2)
Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases (1999) (2)
Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis. (2013) (2)
The effect of cirrhosis and ethanol ingestion on hepatic iron deposition in the rat. (1967) (2)
Hereditary diseases of the liver (1998) (2)
Haemolysis in liver disease: relationship to erythrocyte membrane function, serum bilirubin concentration and plasma electrolyte disturbances. (1976) (2)
Hereditary hemochromatosis and liver transplantation: Implications for patient survival, graft function and the pathogenesis of hereditary hemochromatosis. (2002) (2)
[Hereditary primary hemochromatosis or hemochromatosis secondary to alcoholic cirrhosis? Observation of a case complicated by malignant hepatoma and thrombosis of the portal vein]. (1966) (2)
Immunological abnormalities associated with liver disease: cause or effect? (1977) (2)
The changing role of liver biopsy in hereditary haemochromatosis after the cloning of the HFE gene (1998) (2)
A region of primer binding variation at the D6S265 locus associated with HLA-A25 and HLA-A26 antigens (1995) (1)
Auto‐immune chronic active hepatitis: Should we be searching for an elusive (auto) antigen? (1988) (1)
The role of bemigride in the treatment of barbiturate overdose: results of a controlled study. (1962) (1)
EXCLUSION OF A CHROMOSOME-6 FERRITIN SEQUENCE AS A CANDIDATE FOR THE HEMOCHROMATOSIS GENE (1989) (1)
1056 Rats of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: relevance to disease penetrance (2003) (1)
The effect of haemochromatosis genotype on iron indices in young women (1999) (1)
Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasis (2003) (1)
Messenger-Rna levels for type-I, type-Iii and type-Iv procollagen in a rat model of chronic iron overload (1992) (1)
HEMOCHROMATOSIS AND VITAMIN C. AUTHORS' REPLY (1999) (1)
Use of Triton X100 scintillant in a simple method for the simultaneous assay of " Fe and 59 Fe by liquid scintillation counting (1)
STUDIES OF THE INTESTINAL MUCOSAL TRANSPORT OF IRON (1972) (1)
Microsomal enzyme induction in patients with decompensated cirrhosis. (1980) (1)
Effect of phlebotomy on serum ALT levels in patients with non-alcoholic steatohepatitis and stainable hepatic iron (2001) (1)
Bilirubin metabolism and jaundice with special reference to unconjugated hyperbilirubinaemia. (1967) (1)
Tissue damage in haemochromatosis: an analysis of the roles of iron and alcoholism. (1970) (1)
Reply to HEP 16‐0784.R1 and HEP 16‐0898 (2016) (1)
Hepatitis B antigen and antibody in active chronic hepatitis and other liver diseases in Australia (1975) (1)
The effect of progressive parenchymal liver disease on body fat and body cell mass (1990) (1)
GILBERT'S DISEASE: HAS IT EVER EXISTED? (1977) (1)
Reticuloendothelial phagocytic function in human liver diseases. (1970) (1)
Exome Sequencing Identifies a GNPAT Variant Associated with Severe Iron Overload in HFE C282Y Homozygous Men with Extreme Phenotypes; Possible Role in Regulation of Hepcidin Expression (2014) (1)
Enhancement of hepatic drug metabolism by glutethimide in patients with liver disease (1979) (1)
Chronic Hepatitis (1984) (1)
Progress Report - the Queensland Liver-Transplant Program (1988) (1)
Enhanced drugmetabolism incigarette smokers (1976) (1)
Where does the gene for hemochromatosis lie in relation to HLA-A? (1994) (1)
Association of the HFE C282Y mutation with porphyria cutanea tarda in Australian patients The 47th Annual Meeting of the American Society of Human Genetics was held in Baltimore, Maryland, October 28 to November 1, l997 (1997) (1)
Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease (2005) (1)
Red cell survival in experimental cholestatic cholestatic jaundice. (1968) (1)
The assessment of total body iron stores using the chelating agent diethylene-triamine penta-acetic acid (D.T.P.A.). Its significance for human haemochromatosis. (1966) (1)
HbO-Arab mutation originated in the Pomak population of Greek Thrace (2005) (1)
Book Review Proteins of Iron Metabolism Edited by Ugo Testa. 559 pp., illustrated. Boca Raton, Fla., CRC Press, 2002. $199.95. 0-8493-8676-4 (2002) (1)
Genetic hemochromatosis and HLA linkage (1987) (1)
The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screening (2004) (1)
Exome Sequencing Identifies Genes and Variant Alleles Associated With Severity Of Iron Overload In Hemochromatosis HFE C282Y Homozygotes (2013) (1)
Letter: Serum ferritin in hemochromatosis. (1976) (1)
4,644 GRAMMES OF ORAL FERROUS SULPHATE (OVER 19 YEARS) WITHOUT APPARENT DAMAGE (1968) (1)
DESFERRIOXAMINE AND IRON (1964) (1)
Increased hepatic iron stores in non alcoholic steatohepatitis (NASH) are associated with the Cys282Tyr hemochromatosis mutation and increased hepatic fibrosis (1997) (1)
The Queensland Institute of Medical Research (1996) (1)
Fulminant hepatic failure complicating the treatment of Mycobacterium xenopi (1991) (1)
Hepatic iron stores and steatosis are associated with lipid peroxidation and fibrosis (1998) (1)
Changing concepts in haemochromatosis families was emphasized in the Brisbane studies of Harris (2008) (1)
Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a morphological iron index: a study of 192 cases (1992) (1)
Subcutaneous filarial worms in Florida. (1971) (1)
Changing concepts of haemochromatosis. (1994) (1)
HFE AND ALCOHOLIC LIVER DISEASE. AUTHOR'S REPLY (1999) (1)
Hepatic cirrhosis in hereditary hemochromatosis is seldom due soley to iron: evidence for a synergistic effect of alcohol and iron (2000) (0)
Hepatology: Gastroenterology, Vol. 4 – The Liver (1984) (0)
Concordance of iron indices between family members within hemochromatosis families: further evidence that it additional modifying genes influence HFE expression in hemochromatosis (2000) (0)
Oxford Textbook of Clinical Hepatology, 1st Edn., McIntyre N., Benhamou J-P., Bircher J., Rodes J. (Eds.). Oxford University Press, London (1991) (1993) (0)
Subject Index, Vol. 21, 1981 (1981) (0)
Acute Monocvtic Leukemia: Report of Case Treated With Cortisone and 6‐mercaptopurine (1956) (0)
Chronic hepatitis. Aetiology and current management. (1984) (0)
Regression of fibrosis stage after treatment in patients with HFE haemochromatosis and severe fibrosis at diagnosis: relevance to hepatocellular carcinoma (2018) (0)
Table 1. [Summary of Molecular Genetic Testing Used in HFE-HH]. (2015) (0)
SCREENING FOR EARLY IDIOPATHIC HAEMOCHROMATOSIS: SERUM FERRITIN OR HLA TYPING? (1980) (0)
Study Site Differences in GNPAT p.D519G (rs11558492) Allele Frequencies in Men with HFE Homozygosity (2015) (0)
Reply (2015) (0)
Halothane hepatotoxicity: a report of six cases receiving radium therapy for carcinoma of the cervix. (1969) (0)
Hepatic iron overload not due to the C282Y mutation is associated with heavy iron loading in other organs (1999) (0)
Association of GNPAT p.D519G with Higher Iron Phenotypes in Women with HFE p.C282Y Homozygosity (2017) (0)
Possible etiological importance of altered bile salt metabolism in a patient with drug induced hyper lipo proteinemia and cholestasis (1976) (0)
A common deletion at D6S265 in the hemochromatosis gene region (1994) (0)
The relationship between hepatic steatosis and indices of obesity (2000) (0)
Management of the Patient with Ascites (2012) (0)
Specific radioimmunoassays for prednisolone (1977) (0)
Figure 2. [Use of serum ferritin concentration to help direct management]. (2015) (0)
Fundamentals of Gastroenterology (1991) (0)
Liver disease. When drugs may be the cause. (1983) (0)
UseofChromatofocusing to Detecta Transferrin VariantinSerumof Alcoholic Subjects (1985) (0)
Duodenal expression of iron transport genes in untreated hemochromatosis subjects. (2002) (0)
Iron storage at the Royal Free Hospital. (1983) (0)
The normal plantar reflex. (1962) (0)
Effectiveness of regular surveillance for hepatocellular carcinoma in patients with hemochromatosis and cirrhosis: A study of 70 cases (2000) (0)
Diabetes and hemochromatosis (2014) (0)
Liver Function Tests in Abnormal Laboratory Results (2006) (0)
DISTURBED CELL–MEDIATED IMMUNITY IN LIVER DISEASE: CAUSE OR EFFECT? (1977) (0)
John Howard Tyrer CBE, MD, FRCP(Lond), FRCP(Edin), FRACP (2006) (0)
Catheter Ablation in Patients with ICDs (2008) (0)
The transferrin receptor is not essential for HFE synthesis or cell surface expression in CHO cells (1999) (0)
THE DIAGNOSIS OF PANCREATITIS (1977) (0)
High frequency of loss of heterozygosity on chromosomes 1p, 4p, 4q, 9p, 13q, and 17p in hepatocellular carcinomas from Australia and South Africa (2001) (0)
The Influence of Iron Loading On Free-Radical Scavenging Enzymes in the Liver (1986) (0)
Non-Hfe Haemochromatosis: a Phenotypic and Clinical Analysis of Published Cases and Comparison with Hfe-Haemochromatosis (2017) (0)
HUMAN ISOFERRITINS (1975) (0)
Tissue Isoferritin Distribution in Idiopathic Haemochromatosis and Other Iron Storage Diseases (1976) (0)
The clinical relevance of compound heterozygosity for the haemochromatosis mutations (C282Y/H63D) (2006) (0)
Metals and the liver: receptacles to receptors and recombinant DNA. (1984) (0)
Effects of Allopurinol on Iron Storage in the Rat (1966) (0)
Contents, Vol. 21, 1981 (1981) (0)
Enhanced hepatic lipid peroxidation in genetic hemochromatosis; reversal by phlebotomy (1996) (0)
Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases (1999) (0)
Non-C282Y hepatic iron overload is associated with heavy iron loading in other organs (1999) (0)
Metabolic liver disease (1993) (0)
Highresolution single strand conformation polymorphism analysis using formamide and ethidium bromide staining (1997) (0)
Treatment of Burkitt lymphoma: A single institution's experience (2005) (0)
The effect of steatosis on iron homeostasis in HuH-7 hepatoma cells (2006) (0)
Comparative analysis of three major textbooks of hepatology (2000) (0)
HFE-COMPOUND HETEROZYGOTES WITH SERUM FERRITIN < 1000 UG/L AT AGE 65 ARE NOT AT INCREASED RISK OF HEMOCHROMATOSIS COMPARED TO HFE WILD-TYPE CONTROLS (2008) (0)
Diagnosis of Subjects: Pre t: qmochromatosis in Young 'idtive Accuracy of Biochemical Screening Tests (1984) (0)
An investigation of carbohydrate deficient transferrin (CDT) in a large twin-based population study of alcohol dependence (1996) (0)
982 PHLEBOTOMY IS ASSOCIATED WITH AN IMPROVEMENT IN LIVER ENZYMES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND INCREASED HEPATIC IRON STORES (2008) (0)
Exome Sequencing in Hfe C282Y Homozygotes with Extreme Hepatic Iron Overload Reveals Modifying Genes for the Development of Cirrhosis (2016) (0)
Non-HFE related haemochromatosis in Australia (2001) (0)
INDEPENDENT ASSOCIATION OF GNPAT p.D519G WITH MARKEDLY INCREASED IRON STORES IN HFE p.C282Y HOMOZYGOTES (2017) (0)
Liver Disease (2012) (0)
Reply to: GNPAT variant is associated with iron phenotype in healthy Taiwanese women: A population without the HFE C282Y mutation (2016) (0)
Honorary chief editor (2013) (0)
Clinical expression of HFE-associated haemochromatosis in subjects under 40 years of age (2010) (0)
The Natural-History of Non Alcoholic Steatohepatitis (Nash) - An Analysis of 35 Patients Followed for Up to 20 Years (1988) (0)
BILATERAL ENLARGEMENT OF PAROTID GLANDS DUE TO MULTIPLE MYELOMA. (1964) (0)
Workplace-Based Genetic Screening for the Prevention of HFE-Associated Hereditary Haemochromatosis: An Exploratory Cost-Effectiveness Analysis (2007) (0)
Reply (2016) (0)
Hemochromatosis and Other Diseases Associated with Iron Overload (2018) (0)
Book ReviewWright's Liver and Biliary Disease, 3rd Edn., Millward-Sadler G.H., Wright R., Arthur M.J.P. (Eds.), W.B. Saunders, Philadelphia (1992) (1993) (0)
Autoimmune Chronic Active Hepatitis (cah) and Systemic Lupus-Erythematosus (sle) - Separate Entities or Overlapping Diseases (1986) (0)
Table 2. [Selected HFE Pathogenic Allelic Variants]. (2015) (0)
Letter: Hemochromatosis. (1975) (0)
GNPAT Variant Associated With Severe Iron Overload in HFE Hemochromatosis Reply (2015) (0)
Loss of heterozygosity at 4q in hepatocellular carcinoma is more common in patients with hepatitis B infection (1999) (0)
Alterations of drug metabolism in rats exposed to cigarette smoke. (1980) (0)
Liver and Drugs (1973) (0)
The effect of alcohol on beta-galactoside 2,6 sialyltransferase expression and activity in HEPG2 cells in culture (1996) (0)
Cellular Immunity to Liver Protein and Suppressor T Lymphocyte Activity in Liver Injury in Mice (1980) (0)
Diabetes is associated with fibrosis progression in haemochromatosis (2010) (0)
The nature and mechanism of haemolysis in experimental liver diseases. (1969) (0)
Reply (2001) (0)
Changes in hepatic matrix degradation in prefibrotic and fibrotic haemochromatosis (1998) (0)
Up-regulation of P73 in hepatocellular carcinoma (1999) (0)
Outcome analysis of a hospital-based screening strategy for C282Y hereditary haemochromatosis (HHC) (2001) (0)
Isolating and characterising the haemochromatosis gene. (1989) (0)
Prednisolone effects on monocyte chemotaxis: Normal subjects and patients on long-term steroid therapy (1980) (0)
Anti-mitochondrial antibodies: what’s new? (2011) (0)
Erythrocyte ferritin as an indicator of body iron stores in patients with anemia of chronic disease (1985) (0)
Heparin cofactor deficiency and instability as reflected by the 24-hour heparin clot inhibition test. (1968) (0)
UseofTriton X-100scintillant inasimple method forthesimultaneous assay of"Feand 59Fe byliquid scintillation counting (1970) (0)
ANAEMIA, STEATORRHOEA AND JAUNDICE. (1964) (0)
Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases (1999) (0)
Differences in Clinical Manifestations of Hemochromatosis in Hfe C282Y Homozygotes with Extreme High and Low Iron Phenotypes (2016) (0)
Universal occurrence of renal abnormalities in patients receiving liver transplants (1991) (0)
PHYSICAL AND GENETIC-MAPPING OF HLA-F ON 6P213 (1991) (0)
Cirrhosis of liver - comparative study of 4 major aetiological groups (1971) (0)
Reply: Hemochromatosis mutation in hepatitis C: Histopathology - (1998) (0)
Kunio Okuda 21 May 1921 – 2 February 2003 (2003) (0)
Reply (2016) (0)
Drugs in Gastroenterology (1969) (0)
PS-096-Validation study of the impact of hepatic iron concentration on the development of advanced hepatic fibrosis in HFE hemochromatosis (2019) (0)
IDENTIFICATION OF GENES AND VARIANT ALLELES ASSOCIATED WITH IRON OVERLOAD IN HEMOCHROMATOSIS HFE C282Y HOMOZYGOTES (2013) (0)
Mononuclear cell factors and collagen synthesis (1982) (0)
Widespread promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa (2001) (0)
Figure 1. [Algorithm for screening for HFE-associated...]. (2015) (0)
HFEand alcoholic liver disease (1999) (0)
Cimetidine-Induced Mental Confusion in Patients with Cirrhosis (1986) (0)
ANÆMIA, STEATORRHŒA AND JAUNDICE (1964) (0)
The detection of early hemochromatosis (1978) (0)
DIAGNOSIS OF HEMOCHROMATOSIS. AUTHORS' REPLY (1999) (0)
INDEPENDENT RISK FACTORS FOR BIOPSY-PROVEN CIRRHOSIS IN HEMOCHROMATOSIS: A STUDY OF 110 HFE p.C282Y HOMOZYGOTES WITH GNPAT p.D519G GENOPTYING (2017) (0)
Glomerular lesions in cirrhosis: relationship to post liver transplant renal failure (1991) (0)
Changes in body composition following liver transplantation (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Lawrie William Powell?

Lawrie William Powell is affiliated with the following schools:

University of Queensland